NEW YORK — The Food and Drug Administration announced Thursday that it is investigating a possible link between the widely used asthma drug Singulair and reports of mood swings and suicidal behavior.
The FDA has requested Singulair’s manufacturer Merck & Co. evaluate the drug’s data, and is reviewing reports it has received of patients who claim behavior and mood changes after taking the drug. More... Discount Magazine Subscriptions - Discount Cigarettes & Tobacco - Nutty News Marketplace - Books-A-Million
The FDA has requested Singulair’s manufacturer Merck & Co. evaluate the drug’s data, and is reviewing reports it has received of patients who claim behavior and mood changes after taking the drug. More... Discount Magazine Subscriptions - Discount Cigarettes & Tobacco - Nutty News Marketplace - Books-A-Million
